A Study of Depemokimab in Participants of 6 to 11 Years of Age
Clinical trial NCT07671001 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07671001
- Sponsor
- GlaxoSmithKline
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-26
- Primary completion
- 2029-03-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.